reported a combined analysis of the density of tumor-associated immune cells and their location may help predict patient survival in laryngeal cancers, like a high density of intratumoral CD68+ cells and peritumoral CD163+ cells were significantly associated with poor OS durations (49). This evidence concerns the gene CD163 and neoplasm.